Aesclapius Pharmaceuticals Private Limited
About Aesclapius Pharmaceuticals Private Limited
Data last updated:
Aesclapius Pharmaceuticals Private Limited is a private limited company based in Purnia, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 October 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74900BR2010PTC016171. Its GSTIN is 10AAICA9130E1Z8 (Bihar).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nand Kishor Prasad and Ved Prakash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Adarsh Nagar Bari Hatt, Purnia, Bihar, India – 854301.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.69 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.73 Lakh (net margin 6%) and EBITDA of ₹2.39 Lakh (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aesclapius Pharmaceuticals Private Limited's registered office is in Purnia, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAdarsh Nagar Bari Hatt, Purnia, Bihar, India – 854301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aesclapius Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aesclapius Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aesclapius Pharmaceuticals Private Limited, buy the company report.
Financials of Aesclapius Pharmaceuticals Private Limited
FY 2025 filings availableAesclapius Pharmaceuticals Private Limited reported revenue of ₹28.69 Lakh (up 240% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 240% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 18%. EBITDA rose 253% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aesclapius Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aesclapius Pharmaceuticals Private Limited
Aesclapius Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nand Kishor Prasad | Director | 12 Oct 2010 | 16 Years 0 Months | Current |
| Ved Prakash | Director | 12 Oct 2010 | 16 Years 0 Months | Current |
Peer comparison
Aesclapius Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baidyanath Horti.Agro and Plantations Private Limited | ₹28.75 Lakh (FY 2024) | -28.0% | Mumbai, Maharashtra, India | |||
| Solange Pharmaceuticals Private Limited | ₹28.71 Lakh (FY 2025) | 3.0% | Vadodara, Gujarat, India | |||
| Aesclapius Pharmaceuticals Private Limitedthis company | ₹28.69 Lakh (FY 2025) | ₹1.73 Lakh | 6% | 240.0% | Purnia, Bihar, India | |
| Eureka Farmland Private Limited | ₹28.61 Lakh (FY 2025) | 2019.0% | Delhi, India | |||
| Rasathanthra Pharmaceuticals Pvt Ltd | ₹28.6 Lakh (FY 2025) | 0.0% | Palghat, Kerala, India | |||
| Sanvik Pharmaceuticals Private Limited | ₹28.57 Lakh (FY 2025) | 4.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Aesclapius Pharmaceuticals Private Limited, buy the company report.
Auditor
Aesclapius Pharmaceuticals Private Limited is audited by SANTOSH BHAUMIK AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANTOSH BHAUMIK AND CO | FY 2017 | 322039E |
Shareholding
The shareholding of Aesclapius Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aesclapius Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aesclapius Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aesclapius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aesclapius Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Aesclapius Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICA9130E1Z8 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aesclapius Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aesclapius Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Nand Kishor Prasad was appointed as Director on 12 Oct 2010.
Frequently asked questions
Aesclapius Pharmaceuticals is an active private limited company based in Purnia, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 October 2010 (16+ years old) and is registered under CIN U74900BR2010PTC016171.
Aesclapius Pharmaceuticals has 2 current directors:
- Nand Kishor Prasad - Director
- Ved Prakash - Director
The latest financial statements of Aesclapius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aesclapius Pharmaceuticals is 10AAICA9130E1Z8, registered in Bihar.
The CIN (Corporate Identification Number) of Aesclapius Pharmaceuticals is U74900BR2010PTC016171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aesclapius Pharmaceuticals was incorporated on 12 October 2010, making it 16+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Aesclapius Pharmaceuticals by revenue are Baidyanath Horti.Agro and Plantations Private Limited, Solange Pharmaceuticals Private Limited, Eureka Farmland Private Limited, Rasathanthra Pharmaceuticals Pvt Ltd, Sanvik Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nand Kishor Prasad was appointed as Director on 12 Oct 2010. Ved Prakash was appointed as Director on 12 Oct 2010.
The registered office of Aesclapius Pharmaceuticals is at Adarsh Nagar Bari Hatt, Purnia, Bihar, India – 854301.
Aesclapius Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Aesclapius Pharmaceuticals is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
